Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.81 |
| ▸ | DRD2 | P14416 | 1/20 | 0.81 |
| ▸ | DRD1 | P21728 | 1/20 | 0.81 |
| ▸ | HTR1B | P28222 | 1/20 | 0.81 |
| ▸ | HTR2A | P28223 | 1/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL9304567 | 0.96 | HTR1A (0.75) | HTR1ADRD2DRD1HTR1BHTR2A | |
| SCHEMBL9305727 | 0.94 | HTR1A (0.71) | HTR1ADRD2DRD1HTR1BHTR2A | |
| SCHEMBL13532497 | 0.90 | HTR1A (0.98) | HTR1ADRD2DRD1HTR1BHTR2A | |
| Alnespirone SCHEMBL114478 | 0.90 | HTR1A (1.00) | HTR1ADRD2DRD1HTR1BHTR2A | |
| Alnespirone SCHEMBL13532499 | 0.90 | HTR1A (1.00) | HTR1ADRD2DRD1HTR1BHTR2A | |
| Alnespirone SCHEMBL29639699 | 0.90 | HTR1A (1.00) | HTR1ADRD2DRD1HTR1BHTR2A | |
| Alnespirone SCHEMBL29349572 | 0.89 | HTR1A (0.98) | HTR1ADRD2DRD1HTR1BHTR2A | |
| Alnespirone SCHEMBL114479 | 0.89 | HTR1A (0.98) | HTR1ADRD2DRD1HTR1BHTR2A | |
| Alnespirone SCHEMBL29390957 | 0.89 | HTR1A (0.98) | HTR1ADRD2DRD1HTR1BHTR2A | |
| SCHEMBL9304340 | 0.89 | HTR1A (0.64) | HTR1ADRD2DRD1HTR1BHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5322944-A | Process for the synthesis of enantiomers of 3-aminochroman compounds | ADIR ET COMPAGNIE (FR) | 1994-06-21 | — | — | US | claimed |
| EP-0452204-B1 | 3-Aminochromane derivatives, procedure for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1994-06-15 | — | — | EP | claimed |
| US-5252578-A | Treatment of disorders of teh serotoninergic system | ADIR ET COMPAGNIE (FR) | 1993-10-12 | — | — | US | claimed |
| EP-0452204-A1 | 3-Aminochromane derivatives, procedure for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1991-10-16 | — | — | EP | claimed |
| US-5346916-A | FOR TREATING ANIMALS SUFFERING FROM DISORDERS OF THE SEROTONINERGIC SYSTEM | ADIR ET COMPAGNIE (FR) | 1994-09-13 | — | — | US | disclosed |
| US-5322944-A | Process for the synthesis of enantiomers of 3-aminochroman compounds | ADIR ET COMPAGNIE (FR) | 1994-06-21 | — | — | US | disclosed |
| EP-0452204-B1 | 3-Aminochromane derivatives, procedure for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1994-06-15 | — | — | EP | disclosed |
| US-5273994-A | Also hydroxy- or alkyl ether-substituted | ADIR ET COMPAGNIE (FR) | 1993-12-28 | — | — | US | disclosed |
| US-5252578-A | Treatment of disorders of teh serotoninergic system | ADIR ET COMPAGNIE (FR) | 1993-10-12 | — | — | US | disclosed |
| EP-0452204-A1 | 3-Aminochromane derivatives, procedure for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1991-10-16 | — | — | EP | disclosed |